Invoke Capital

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in AI-driven document analysis software. It serves multinational and governmental organizations, offering a platform that accurately reviews, categorizes, and analyzes legal documents and contracts. The software identifies risk clauses, enables task allocation and progress tracking, and provides data visualization and anomaly detection. It also streamlines contract generation, negotiation, and post-execution analysis, helping businesses manage contract-related workflows efficiently.

Featurespace is a leading company specializing in enterprise financial crime prevention, focusing on fraud and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are integrated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries, allowing financial institutions to detect suspicious activities and mitigate fraud in real-time. The ARIC Risk Hub employs advanced anomaly detection techniques to help organizations identify and respond to emerging fraud threats while ensuring legitimate customer transactions are not hindered. With over 30 major global financial institutions utilizing its platform, Featurespace aims to enhance fraud management, improve customer satisfaction, and drive revenue growth for its clients.

Featurespace is a leading company specializing in enterprise financial crime prevention, focusing on fraud and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are integrated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries, allowing financial institutions to detect suspicious activities and mitigate fraud in real-time. The ARIC Risk Hub employs advanced anomaly detection techniques to help organizations identify and respond to emerging fraud threats while ensuring legitimate customer transactions are not hindered. With over 30 major global financial institutions utilizing its platform, Featurespace aims to enhance fraud management, improve customer satisfaction, and drive revenue growth for its clients.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in AI-driven document analysis software. It serves multinational and governmental organizations, offering a platform that accurately reviews, categorizes, and analyzes legal documents and contracts. The software identifies risk clauses, enables task allocation and progress tracking, and provides data visualization and anomaly detection. It also streamlines contract generation, negotiation, and post-execution analysis, helping businesses manage contract-related workflows efficiently.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.

Neurence Limited is a technology company based in Cambridge, United Kingdom, specializing in self-learning artificial intelligence software solutions. Founded by a team of mathematicians and software engineers, Neurence has developed a cloud-based platform that acts as a central repository for information, enabling devices to perceive and interpret the world around them. This innovative platform allows devices to outsource their processing needs to Neurence's intelligent cloud, which leverages advanced mathematical and computational algorithms. By communicating sensory data to the cloud, devices can access accumulated knowledge and respond to various situations more effectively and efficiently. Neurence's system continuously learns from the experiences of connected devices, thereby optimizing their performance and reducing the need for significant on-board processing power. This capability allows for the development of lighter, faster, and more cost-effective devices, ultimately enhancing their functionality in understanding complex, unstructured environments.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.